Predictive imaging insights
Altis Labs’ platforms uses medical imaging to better predict patient outcomes and accelerate therapeutic development. The platform enables imaging data acquisition from trial sites and generates clinically meaningful predictions from imaging data.
The company is headquartered in Toronto, CanadaView website
Why we invested in Altis Labs
Current methods of image interpretation are limited and cannot comprehend the vast amounts of data and images. Altis’s promising technology, applying deep learning to imaging has the potential to significantly reduce time and costs of clinical trials while also predicting patient outcomes more accurately. Extracting new imaging digital biomarkers from longitudinal images can help Debiopharm accelerate time to market and improve success rates of our trials. The company is also exploring digital twins which we could leverage using virtual control arms.
Discover how we can help you bring your ambition to life
June 21, 2023
Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical…